Here we provide a selection of scientific publications related to IOZK immunotherapy. You can use the filters to make a selection according to tumor types and methods, or enter search terms.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-02-26 / J. Nucl. Med. 2015 Apr;56(4):530-7https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-02-26 / J. Nucl. Med. 2015 Apr;56(4):530-72015-02-26 00:00:002019-02-15 09:37:54PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-02-11 / Cancer Res. 2015 Apr;75(7):1265-74https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-02-11 / Cancer Res. 2015 Apr;75(7):1265-742015-02-11 00:00:002019-02-15 08:53:32Antitumor Responses Stimulated by Dendritic Cells Are Improved by Triiodothyronine Binding to the Thyroid Hormone Receptor β
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-02-05 / Molecules 2015 Feb;20(2):2728-69https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-02-05 / Molecules 2015 Feb;20(2):2728-692015-02-05 00:00:002015-02-05 00:00:00The multifaceted role of curcumin in cancer prevention and treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-01-23 / Int. J. Oncol. 2015 Apr;46(4):1699-709https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-01-23 / Int. J. Oncol. 2015 Apr;46(4):1699-7092015-01-23 00:00:002019-02-15 08:52:05Immune responses in patients with esophageal cancer treated with SART1 peptide-pulsed dendritic cell vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-01-22 / Br. J. Haematol. 2015 May;169(3):356-67https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-01-22 / Br. J. Haematol. 2015 May;169(3):356-672015-01-22 00:00:002019-02-15 08:45:29Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-01-15 / J Cancer 2015;6(3):203-17https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-01-15 / J Cancer 2015;6(3):203-172015-01-15 00:00:002021-11-15 13:29:28Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-01-01 / Anticancer Res. 2015 Jan;35(1):555-62https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-01-01 / Anticancer Res. 2015 Jan;35(1):555-622015-01-01 00:00:002019-02-15 08:52:28Prognostic markers for patient outcome following vaccination with multiple MHC Class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002014-12-01 / Int J Hyperthermia 2014 Dec;30(8):531-9https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2014-12-01 / Int J Hyperthermia 2014 Dec;30(8):531-92014-12-01 00:00:002019-02-15 09:17:07Local tumour hyperthermia as immunotherapy for metastatic cancer
Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence
PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma
Hyperthermia Sensitizes Glioma Stem-like Cells to Radiation by Inhibiting AKT Signaling
Dendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer
Hyperthermia restores apoptosis induced by death receptors through aggregation-induced c-FLIP cytosolic depletion
Antitumor Responses Stimulated by Dendritic Cells Are Improved by Triiodothyronine Binding to the Thyroid Hormone Receptor β
The multifaceted role of curcumin in cancer prevention and treatment
A vaccine strategy with multiple prostatic acid phosphatase-fused cytokines for prostate cancer treatment
Immune responses in patients with esophageal cancer treated with SART1 peptide-pulsed dendritic cell vaccine
Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study
Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?
Immunotherapy for castration-resistant prostate cancer: Progress and new paradigms
Potential approaches for more successful dendritic cell-based immunotherapy
Prognostic markers for patient outcome following vaccination with multiple MHC Class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for pancreatic cancer
EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMA
Immunotherapy for malignant gliomas
Immunotherapy of hepatocellular carcinoma
Dendritic cell-based vaccine research against cancer
Local tumour hyperthermia as immunotherapy for metastatic cancer
Prof. Dr. Schirrmacher publishes e-book: Harnessing Oncolytic Virus-mediated Antitumor Immunity